Evidence map›Paper›PMID 36278210›Full record

ArticleFrontiers in pharmacology2022

Yuanfang Sun, Guoliang Cheng, Lijing Du, Yu Gan, Bing Li, Shikai Yan, Mingguo Shao, Huizi Jin, Shasha Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Exploring the effects ofFrontiers in pharmacology · 2025
    Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yuanfang SunThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Guoliang ChengState Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Lunan Pharmaceutical Group Co.,Ltd, Linyi, China.
Lijing DuThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Yu GanThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Bing LiSchool of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
Shikai YanThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Mingguo ShaoState Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Lunan Pharmaceutical Group Co.,Ltd, Linyi, China.
Huizi JinSchool of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
Shasha LiThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Guangzhou University of Chinese Medicine · CNShanghai Jiao Tong University · CNBeijing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chuanzhitongluo capsuleefficacy outcomelaser speckle contrast imagingmechanism explorationmicrocirculatory dysfunction

Identifiers

PMID36278210
PMCPMC9585327
OpenAlexW4303183172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.